- 米国企業
- HERON THERAPEUTICS, INC.
HERON THERAPEUTICS, INC.HRTX
時価総額
$3億
PER
2011年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Cash and cash equivalents | 18 | 54 | 72 | 73 | 75 | 13 | 145 | 32 | 72 | 105 | 91 | 15 |
Short-term investments | - | - | - | - | - | - | - | - | 319 | 103 | 67 | 69 |
Accounts receivable, net | - | - | - | - | - | 2 | 42 | 65 | 40 | 42 | 35 | 52 |
Inventory | - | - | - | - | - | 5 | 10 | 39 | 25 | 42 | 48 | 55 |
Prepaid expenses and other current assets | 0 | 1 | 1 | 1 | 4 | 4 | 4 | 11 | 23 | 22 | 13 | 14 |
Total current assets | 18 | 54 | 73 | 74 | 135 | 62 | 228 | 447 | 479 | 314 | 254 | 205 |
Property and equipment, net | 1 | 2 | 3 | 3 | 3 | 5 | 6 | 15 | 20 | 23 | 24 | 22 |
Right-of-use lease assets | - | - | - | - | - | - | - | - | 14 | 16 | 10 | 8 |
Other assets | 0 | 0 | 0 | 0 | 45,000 | 0 | 0 | 0 | 0 | 0 | 18 | 16 |
Total assets | 19 | 56 | 76 | 77 | 138 | 67 | 234 | 462 | 513 | 354 | 306 | 251 |
Accounts payable | 1 | 2 | 1 | 3 | 3 | 7 | 19 | 17 | 3 | 1 | 4 | 3 |
Accrued Clinical Liabilities | - | - | - | 4 | 5 | 13 | 27 | 24 | 35 | 50 | 24 | 24 |
Employee-related Liabilities, Current | - | - | - | 3 | 5 | 8 | 9 | 13 | 15 | 14 | 15 | 13 |
Other accrued liabilities | - | - | - | 3 | 4 | 6 | 17 | 33 | 37 | 28 | 26 | 39 |
Current lease liabilities | - | - | - | - | - | - | - | - | 2 | 3 | 2 | 3 |
Convertible Notes Payable Related Parties Current | - | - | 1 | 2 | 2 | 3 | 4 | 5 | 6 | 7 | - | - |
Total current liabilities | 4 | 4 | 7 | 14 | 20 | 39 | 103 | 92 | 97 | 103 | 71 | 82 |
Non-current lease liabilities | - | - | - | - | - | - | - | - | 12 | 15 | 8 | 5 |
Convertible Notes Payable, Noncurrent | - | - | - | - | - | - | - | - | - | - | 149 | 149 |
Other non-current liabilities | - | - | - | - | - | - | - | - | - | - | - | 0 |
Total liabilities | 4 | 4 | 7 | 14 | 20 | 89 | 103 | 92 | 109 | 117 | 228 | 237 |
Preferred Stock, Value, Issued | - | - | - | - | - | - | - | - | - | - | - | - |
Common Stock, Value, Issued | 2 | 3 | 0 | 0 | 361,000 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Additional paid-in capital | 174 | 232 | 308 | 378 | 531 | 564 | 914 | 1,330 | 1,568 | 1,628 | 1,690 | 1,808 |
Accumulated other comprehensive loss | - | - | - | - | -40,000 | -0 | -0 | -0 | 0 | 0 | -0 | -0 |
Accumulated deficit | -160 | -184 | -239 | -315 | -412,828,000 | -586 | -783 | -961 | -1,165 | -1,393 | -1,600 | -1,800 |
Total stockholders’ equity | 16 | 52 | 69 | 63 | 118 | -21 | 131 | 370 | 404 | 236 | 78 | 14 |
Total liabilities and stockholders’ equity | 19 | 56 | 76 | 77 | 138 | 67 | 234 | 462 | 513 | 354 | 306 | 251 |